ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

BVXP Bioventix Plc

3,900.00
0.00 (0.0%)
01 Dec 2023 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Bioventix Plc LSE:BVXP London Ordinary Share GB00B4QVDF07 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 3,900.00 3,850.00 3,950.00 3,900.00 3,900.00 3,900.00 3,833 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 12.82M 8.37M 1.6071 24.27 203.16M

Bioventix Share Discussion Threads

Showing 1201 to 1225 of 1550 messages
Chat Pages: Latest  50  49  48  47  46  45  44  43  42  41  40  39  Older
DateSubjectAuthorDiscuss
21/4/2020
15:53
Interesting chippy thanks. Long term hold for me regardless (and has been for many years).
hydrus
21/4/2020
15:29
Hydrus,

Many of those admitted to hospital with covid 19 will have their troponin levels checked, as the actions of the virus can damage the heart.

chippyfriday
16/4/2020
10:20
'Within the field of our customers in downstream in vitro diagnostics, it is possible that some routine diagnostic testing could be reduced as hospitals refocus towards virus-infected patients and this could have an impact on Bioventix into the future. '
hydrus
16/4/2020
10:19
Impact on BVXP potentially in short term, which they alluded to in the results: https://www.theguardian.com/world/2020/apr/16/coronavirus-concern-heart-attack-stroke-patients-delay-seeking-help
hydrus
03/4/2020
06:03
Don't forget the new shares weren't freebies. He had to raise the cash to pay for them and the benefit of the discount to the market price would be subject to income tax at his highest rate, payable at the time as paye.
melton john
03/4/2020
03:03
In relation to his holding not that big! Please note:

Following the Sale and the Exercise, Peter Harrison's total beneficial interest
in the Company will be 416,676 Ordinary Shares representing approximately 8.0%
of the Company.

Wish I had as many!

lauders
02/4/2020
13:54
Big director dump
dan_the_epic
31/3/2020
13:44
Hi ScillyFool,

Agreed, a very positive report and maintaining the dividend, whilst so many firms are cancelling or deferring, is a huge sign of confidence.

The Troponin growth was the highlight amongst the other other good news, whilst a tab behind management's expectations, it bodes very well for the future.

Regards, Maddox

maddox
30/3/2020
20:44
Nice to see the Board are going to continue with the progressive dividend policy. A 20% increase in the interim dividend added to the usual increased final and the increased special dividend make this a no-brainer AIM share. Even the share price is heading back up towards the £40 mark. Wish I'd bought more last week!
scillyfool
30/3/2020
11:44
I wonder how ONJohn's short is performing?
maddox
30/3/2020
08:00
Even better they are ex Divi next week and paid in under a month from today. If only all companies returned our cash so promptly.

Slightly disappointing comments about Troponin but the market seems happy enough.

StepOne

stepone68
30/3/2020
06:19
despite all the companies pulling dividends ebioventix seeming able to sail serenely on and increase the divi substantially. Might have to buy : )
nimbo1
19/3/2020
18:20
From Stockopedia today:

Why BVXP is a buy with a strong moat.

1. High rates of Free Cash Flow - the measure of a thriving company.
- A high ratio of free cash flow to sales can be a very positive sign. For Bioventix, the figure is an impressive 62.4%.

2. High Return on Capital Employed - the measure of a company growing efficiently and profitably.
- A 5-year average ROCE of more than 12 percent is a pointer to strong efficiency. For Bioventix, the figure is an eye-catching 56.0%.

3. High Return on Equity (compared to peers) - the measure of a company making good profits from its assets.
- Bioventix has a 5-year average ROE of 50.3%.

4. High Operating Margins (compared to peers) - the measure of a company with pricing power
- Bioventix has a 5-year average operating margin of 75.9%.

scillyfool
18/3/2020
22:43
I agree M9999, down less then every other share on my watch list of 30+.
luderitz
18/3/2020
21:34
ONJohn filtered - IMV he is short a number of shares and just trying to drive the share price down - comments have no foundation.

BVXP is a long term business and will suffer minimal impact from the Coronavirus

melody9999
18/3/2020
18:53
What the turkey?
luderitz
18/3/2020
17:49
Less tests being carried out now

This will warn and drop to 12 pounds

onjohn
18/3/2020
00:23
I have no idea of the present price of poultry but thanks for keeping us up to speed on it ONJ..
luderitz
17/3/2020
20:11
Overpriced turkey
onjohn
10/3/2020
03:32
Information such as this will do no harm to BVXP:



Hope this virus passes but seems we are going to have to be patient! Stay safe everyone.

lauders
07/3/2020
22:06
This one’s been on the up recently when others seem to be still going the other way, this I like 😃
luderitz
28/2/2020
12:37
Yes, I remember you calling the 20% rise when it touched 30 quid in December.

Oh. Wait a minute. You didn't.

stepone68
28/2/2020
12:13
Chart seen double top. £31 looks obvious short term target
techtrader5
27/2/2020
12:19
Agreed probably one of the last ones more like.
luderitz
27/2/2020
11:16
LOL - anything medical related won't be warning.
igbertsponk
Chat Pages: Latest  50  49  48  47  46  45  44  43  42  41  40  39  Older

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com